S, O., E, P., G, S., D, P., L, S., MR, M., . . . MR, D. M. (2022). Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes. Biomedicines, 10(1), . https://doi.org/10.3390/biomedicines10010164
Chicago Style (17th ed.) CitationS, Orrù, et al. "Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes." Biomedicines 10, no. 1 (2022). https://doi.org/10.3390/biomedicines10010164.
MLA (9th ed.) CitationS, Orrù, et al. "Prognostic Role of Androgen Receptor Expression in HER2+ Breast Carcinoma Subtypes." Biomedicines, vol. 10, no. 1, 2022, https://doi.org/10.3390/biomedicines10010164.
Warning: These citations may not always be 100% accurate.